3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Dermatologic
1
Conditions
Melanoma
2
Lung Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
2
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
motexafin gadolinium
1
cabozantinib
1
brodalumab
1
Tomography, Optical Coherence
1
Taxes
1
Surveys and Questionnaires
1
Spectrometry, Fluorescence
1
Sentinel Lymph Node Biopsy
1
Ritonavir
1
Radiotherapy
1
Psychology, Positive
1
Pemetrexed
1
Paclitaxel
1
Optical Imaging
1
Molecular Diagnostic Techniques
1
Methods
1
Ipilimumab
1
Indinavir
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Cisplatin
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Afatinib
×
Dermatologic
×
Clear all
NCT06897735
2026-06-03
EDDIS-a1
Petrov, Andrey
Phase 1
Terminated
4 enrolled